(For a live blog on European stocks, type LIVE/ in an Eikon
news window)
* FTSE 100 down 0.4%, FTSE 250 up 0.1%
* AstraZeneca drops after profit miss
* Coronavirus spread fuels stimulus hopes
Feb 14 (Reuters) - UK blue-chip shares slipped further on
Friday, weighed down by underwhelming results from AstraZeneca
and RBS, while investors remained unsettled due to concerns over
the impact of the coronavirus on the global economy.
The FTSE 100 index .FTSE was 0.4% lower by 0805 GMT and
was set to end the week with a near 1% fall, but the midcap
bourse .FTMC rose 0.1% as it drew strength from the pound.
As the epidemic in China shows no signs of peaking, global
markets may look to central banks to step in and undertake
stimulus measures. Last week, U.S. Federal Reserve Chair Jerome
Powell had warned that economic impact from the virus in China
could spill over globally.
Among corporate news, AstraZeneca AZN.L dropped nearly 4%,
its steepest one-day fall since July 2017, as its quarterly
earnings failed to match up to market expectations. Royal Bank of Scotland RBS.L fell 3.4% after its new top
boss set out a new strategy that included cutting back the size
of its loss-making investment bank and renaming the company
NatWest.